Prevalence of anaemia in chronic heart failure and contribution of Iron deficiency and renal dysfunction as underlying cause

Surendra, C.M. Verma, R. Thakur, R.P.S. Bhardwaj, M. Ahmad, R.K. Bansal, U. Pandey, S.K. Sinha, P. Kumar
2014 Indian Heart Journal  
improvement with a clear increase in cardiac output and decrease in PCWP. Levosimendan was associated with significantly improved dyspnea and a trend towards improved fatigue. Intensive care unit stay in levosimendan group is 1 day shorter than that of the standard treatment group. This shows that the hospitalization costs may be reduced by adopting levosimendan treatment.
doi:10.1016/j.ihj.2014.10.217 fatcat:ersq6iqmybapbercofdrleapce